HbA1c, sometimes called the “holy grail” of diabetes monitoring, measures average blood glucose over three months. It reflects how well sugar levels have been controlled during this period, offering a more accurate picture of diabetes risk than single daily readings. When fasting sugar appears normal but HbA1c is high, it signalsthat short-term measurements might be masking chronic hyperglycemia.

Why the Discrepancy Occurs

Several factors can cause this gap between daily readings and long-term markers. Stress, illness, or medication changes might temporarily spike fasting sugar without affecting HbA1c significantly. Conversely, inconsistent testing times or improper fasting can yield falsely normal fasting results while HbA1c accurately captures sustained high sugar levels.

Another cause is the body’s delayed response to glucose fluctuations. The red blood cells analyzed in HbA1c tests retain glucose damage over 90 days, meaning today’s poor control affects next quarter’s results. A person might have perfect fasting numbers today but still develop complications from past high sugar episodes.

Health Implications

Persistent high HbA1c levels increase risks for cardiovascular disease, kidney failure, nerve damage, and vision loss – dangers not reflected in daily sugar checks. The American Diabetes Association emphasizes HbA1c as the primary diagnostic tool because it predicts complications better than fasting plasma glucose alone.

Studies show patients with HbA1c above 7% face six times greater heart disease risk than those below 6.5%, regardless of daily readings. This explains why doctors prioritize HbA1c: it correlates directly with long-term outcomes.

Practical Guidance

Patients receiving normal fasting sugar but high HbA1c should not ignore the latter value. Ideal management combines both metrics: use fasting tests for daily adjustments and HbA1c for strategic planning. Lifestyle changes – balanced diet, regular exercise, and stress management – remain crucial for improving long-term control.

Doctors recommend testing HbA1c every three months for stable patients and every three weeks during treatment changes. When discrepancies appear, detailed logs of diet, medication timing, and stress levels help identify hidden patterns affecting glucose metabolism.

Emerging research suggests advanced continuous glucose monitors (CGMs) may bridge this gap by providing real-time data alongside traditional metrics. Until widespread adoption, patients must treat HbA1c as the comprehensive report card of their diabetes management journey.

Image Source: Google | Image Credit: Respective Owner